Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1998 Feb;36(2):358-61.
doi: 10.1128/JCM.36.2.358-361.1998.

Evaluation of a new competitive immunoassay (BioElisa Syphilis) for screening for Treponema pallidum antibodies at various stages of syphilis

A Ebel  1 , L Bachelart, J M Alonso
Affiliations
Comparative Study

Evaluation of a new competitive immunoassay (BioElisa Syphilis) for screening for Treponema pallidum antibodies at various stages of syphilis

A Ebel et al. J Clin Microbiol. 1998 Feb.

Abstract

The BioElisa Syphilis, a new competitive enzyme immunoassay (EIA) for Treponema pallidum whole antigen that uses specific human immunoglobulin G (IgG) antibodies as the competitor, was evaluated for potential use in screening for syphilis at various stages. The results obtained by this competitive EIA were compared with those obtained by the fluorescent treponemal antibody absorption (FTA-abs) test and the T. pallidum hemagglutination assay (TPHA). Serum samples from 434 patients with positive TPHA and FTA-abs test results, including patients with primary, latent, secondary, and tertiary syphilis and neurosyphilis, were investigated. Two samples tested negative by competitive EIA but were weakly reactive by the TPHA and the FTA-abs test. Sixteen serum samples from patients with clinically documented active syphilis, including several patients infected with human immunodeficiency virus, tested positive by the competitive EIA. There was a direct inverse correlation between EIA indices and titers in the TPHA and the FTA-abs test for all samples that tested positive. Specificity was assessed by testing 358 serum samples which tested negative for syphilis by TPHA and the FTA-abs test, including 100 serum samples from patients with documented infectious or autoimmune diseases. Only two serum samples gave a weakly positive EIA result. Thus, competitive EIA had a sensitivity of 99.5% and a specificity of 99.4% relative to the results of the FTA-abs test and TPHA. Our evaluation shows that BioElisa Syphilis is a sensitive, specific, and simple assay for screening for syphilis.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Correlation between BioElisa Syphilis and TPHA and FTA-abs test (FTA) results. Each point represents the mean EIA index for sera with various TPHA and FTA-abs test titers. The standard error of the mean EIA index was always below 0.27.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alfrod C A, Jr, Polt S S, Cassady G E, Straumfjord J V, Remington J S. Gamma-M-fluorescent treponemal antibody in the diagnosis of congenital syphilis. N Engl J Med. 1969;280:1086–1091. - PubMed
    1. Backhouse J L, Hudson B J. Evaluation of immunoglobulin G enzyme immunoassay for serodiagnosis of Yaws. J Clin Microbiol. 1995;33:1875–1878. - PMC - PubMed
    1. Berkowitz K, Buxi L, Fot H E. False negative syphilis screening: the prozone phenomenon, non-immune hychops and diagnosis of syphilis during pregnancy. Am J Obstet Gynecol. 1990;163:975–977. - PubMed
    1. Burdash N M, Hinds K K, Finnerty J A, Manos J P. Evaluation of the syphilis Bio-EnzaBead assay for detection of treponemal antibody. J Clin Microbiol. 1987;25:808–811. - PMC - PubMed
    1. Centers for Disease Control. Progress toward achieving the 1990 objectives for the nation for sexually transmitted disease. Morbid Mortal Weekly Rep. 1990;39:53–57. - PubMed

Publication types

MeSH terms

LinkOut - more resources